Market News
Matinas BioPharma (MTNB): Q4 2019 Earnings Snapshot
— Matinas BioPharma (NYSE: MTNB) reported loss of $0.04 per share in the fourth quarter of 2019, vs $0.03 per share loss expected. — Initiated ENHANCE-IT study…